My Dashboard
Fin. Planning
Our Solutions
Stocks
Funds
Invest in the best stock opportunities right now and every time.
Start Systematic Stock Investing …in less than a minute.
BSE: 506128 | NSE: | Pharmaceuticals & Drugs | Small Cap
1. Is Parnax Lab Ltd a good quality company?
Data is not available for this company.
2. Is Parnax Lab Ltd undervalued or overvalued?
The key valuation ratios of Parnax Lab Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
3. Is Parnax Lab Ltd a good buy now?
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Parnax Lab Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘValue Creation Index Colour Code Guide ⓘ |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | TTM | |||
| ROCE % ⓘ | 0.6% | -2.7% | -1.5% | -1.3% | 1% | -2.4% | -0.5% | -6.2% | -3.3% | 5.1% | - | ||
| Value Creation Index ⓘ | -1.0 | -1.2 | -1.1 | -1.1 | -0.9 | -1.2 | -1.0 | -1.4 | -1.2 | -0.6 | - | ||
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ |
|||||||||||||
| Sales ⓘ | 25.9 | 17.9 | 15.9 | 7.2 | 5.3 | 5.8 | 6.5 | 7.7 | 2.4 | 7.2 | 7 | ||
| YoY Gr. Rt. % | - | -30.8% | -11.6% | -54.4% | -27% | 9.9% | 11.9% | 18.3% | -69.1% | 201.7% | - | ||
| Adj EPS ⓘ | -1.1 | -2.1 | -1.7 | -1.3 | -0.8 | -1.7 | -1 | -2.4 | -1.3 | 0.5 | 0.4 | ||
| YoY Gr. Rt. % | - | NA | NA | NA | NA | NA | NA | NA | NA | NA | - | ||
| BVPS (₹) ⓘ | 17.7 | 16.2 | 14.8 | 13.7 | 12.9 | 10.2 | 9.2 | 6.9 | 5.5 | 11.1 | 16.2 | ||
| Adj Net Profit ⓘ | -0.9 | -1.8 | -1.5 | -1.1 | -0.7 | -1.4 | -0.9 | -2.1 | -1.1 | 0.5 | 0 | ||
| Cash Flow from Ops. ⓘ | 1.1 | -0.3 | -2.1 | 1.8 | 3.7 | 0.6 | 1.7 | 2.2 | 0.5 | -0.4 | - | ||
| Debt/CF from Ops. ⓘ | 14.5 | -50.3 | -9.1 | 9.5 | 3.3 | 19.4 | 6.7 | 5 | 24.2 | -25.5 | - | ||
CAGR ⓘCAGR Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 Years | 5 Years | 3 Years | 1 Years | |||||||||
| Sales ⓘ | -13.3% | 6.3% | 3.3% | 201.7% | ||||||||
| Adj EPS ⓘ | NA | NA | NA | NA | ||||||||
| BVPS ⓘ | -5 | -2.9 | 6.6 | 101.1 | ||||||||
| Share Price | 1.5% | 7.6% | 62.4% | 114.6% | ||||||||
Key Financial Parameters ⓘPerformance Ratio Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | TTM | ||
| Return on Equity % ⓘ | -5.9 | -12.5 | -11 | -9.4 | -5.9 | -14.5 | -10.4 | -30.4 | -21.5 | 5.6 | 3.1 | |
| Op. Profit Mgn % ⓘ | 3.4 | -0.7 | -2 | -4.3 | 0.1 | 6 | 1.7 | 7 | -19.3 | 19.1 | 16.6 | |
| Net Profit Mgn % ⓘ | -3.4 | -10.1 | -9.2 | -15.8 | -12.6 | -24.6 | -13.2 | -27 | -47.7 | 6.8 | 6.9 | |
| Debt to Equity ⓘ | 1.1 | 1.2 | 1.5 | 1.5 | 1.1 | 1.4 | 1.4 | 1.9 | 2.4 | 0.8 | 0 | |
| Working Cap Days ⓘ | 235 | 322 | 348 | 626 | 527 | 461 | 485 | 346 | 964 | 339 | 1,066 | |
| Cash Conv. Cycle ⓘ | 73 | 156 | 209 | 442 | 355 | 178 | 122 | 61 | 88 | 19 | 919 | |
Return on Equity has increased versus last 3 years average to 3.10%
Debt to equity has declined versus last 3 years average to 0.84
Sales growth is good in last 4 quarters at 55.18%
Sales growth has been subdued in last 3 years 3.28%
Net Profit has been subdued in last 3 years 0.00%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 0.4 | 7.3 |
| TTM Sales (₹ Cr.) | 7 | 178 |
| BVPS (₹.) ⓘ | 16.2 | 50.2 |
| Reserves (₹ Cr.) ⓘ | 7 | 46 |
| P/BV ⓘ | 4.56 | 1.47 |
| PE ⓘ | 177.34 | 10.08 |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 34.00 / 169.90 |
| All Time Low / High (₹) | 8.40 / 190.00 |
| Market Cap (₹ Cr.) | 84.6 |
| Equity (₹ Cr.) | 11.5 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 37.8 |
| Pledged * | 14.68 | 14.68 | 14.68 | 14.68 | 14.68 | 14.68 | 14.68 | 11.78 | 11.78 | 9.41 |
Parnax Lab, earlier known as Krishnadeep Trade and Investments, incorporated in the year 1982, engages in investing and financial businesses in India. The company is based in Mumbai, India. In 2012 the company has changed its name from Krishna Deep Trade & Investments Ltd. to Parnax Lab Ltd. "
In 2009, Krishna Deep Trade and Investments appointed Rasik Chaturvedi and Dilip Pimparkar as additional directors of the company with effect from February 16, 2009. Further, Rasik Chaturvedi and Dilip Pimparkar have also been inducted on the Audit Committee of the Company.
The registered office of the company is 136, Greet Western Building, Nagindas Master Road Extension, Fort Mumbai, Maharashtra-400001.
